Willow bark extract
RxNorm 260012
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 260012 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: willow bark extract.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
Salcaceae extract
(Atom ID: 1308965)
INPrescribable
Ingredient (IN):
Salicin extract
(Atom ID: 12251752)
PTPrescribable
Designated preferred name (PT):
Salicin extract
(Atom ID: 1308960)
FNPrescribable
Full form of descriptor (FN):
Salicin extract (substance)
(Atom ID: 1308966)
SYPrescribable
Synonym (SY):
Willow bark extract
(Atom ID: 11425991)
SYPrescribable
Synonym (SY):
Willow bark extract
(Atom ID: 1308963)
Patient Education
Willow Bark
What is it? Willow bark is the bark from several varieties of the willow tree, including white willow or European willow, black willow or pussy willow, crack willow, purple willow, and others. The bark is used to make medicine.
Willow bark acts a lot like aspirin. It's most commonly used for pain and fever. But there is no good scientific evidence to show that it works as well as aspirin for these conditions.
Coronavirus disease 2019 (COVID-19): Some experts warn that willow bark may interfere with the body's response against COVID-19. There is no strong data to support this warning. But there is also no good data to support using willow bark for COVID-19.
[Learn More]
* Please review the disclaimer below.